Hyperparathyroidism-jaw tumour syndrome
Zuletzt aktualisiert 3. Okt 2024
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Hyperparathyroidism-jaw tumour syndrome is a condition characterised by overactivity of the parathyroid glands (hyperparathyroidism). The four parathyroid glands are located in the neck and secrete a hormone that regulates the body's use of calcium. Hyperparathyroidism disrupts the normal balance of calcium in the blood, which can lead to kidney stones, thinning of the bones (osteoporosis), nausea, vomiting, high blood pressure (hypertension), weakness, and fatigue. About 95 percent of people with hyperparathyroidism-jaw tumour syndrome will develop hyperparathyroidism during their lifetime.
Beschreibung
Hyperparathyroidism-jaw tumour syndrome is a condition characterised by overactivity of the parathyroid glands (hyperparathyroidism). The four parathyroid glands are located in the neck and secrete a hormone that regulates the body's use of calcium. Hyperparathyroidism disrupts the normal balance of calcium in the blood, which can lead to kidney stones, thinning of the bones (osteoporosis), nausea, vomiting, high blood pressure (hypertension), weakness, and fatigue. About 95 percent of people with hyperparathyroidism-jaw tumour syndrome will develop hyperparathyroidism during their lifetime.
In people with hyperparathyroidism-jaw tumour syndrome, hyperparathyroidism is caused by tumours that form in the parathyroid glands. Typically, only one of the four parathyroid glands is affected, but in some people, tumours are found in more than one gland. The tumours are usually a noncancerous (benign) type of tumour called an adenoma. Approximately 15 percent of people with hyperparathyroidism-jaw tumour syndrome develop a cancerous tumour called parathyroid carcinoma.
People with hyperparathyroidism-jaw tumour syndrome may also have a type of benign tumour called a fibroma in the jaw. Even though jaw tumours are specified in the name of this condition, it is estimated that only 11 to 40 percent of affected individuals have this symptom.
Other tumours, both benign and cancerous, are often seen in people with hyperparathyroidism-jaw tumour syndrome. For example, tumours of the uterus occur in up to 50 percent of people with this condition. Uterine tumours are typically benign, but they can cause heavy menstrual bleeding or other symptoms. The kidneys are affected in about 20 percent of people with hyperparathyroidism-jaw tumour syndrome. Benign kidney cysts are the most common kidney feature, but a rare cancerous tumour called Wilms tumour and other types of kidney tumour have also been found.
Regular medical screening may assist in the early detection of the features of hyperparathyroidism-jaw tumour syndrome.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
CDC73-related disorders
Familial cystic parathyroid adenomatosis
Familial primary hyperparathyroidism with multiple ossifying jaw fibromas
Hereditary hyperparathyroidism-jaw tumour syndrome
HPT-JT
Hyperparathyroidism 2
Related patient information and medicines
Patient information leaflet
Hyperparathyreoidismus
Hyperparathyroidism occurs when too much parathyroid hormone is released by the parathyroid glands in the neck. Was ist hyperparathyroidism. In hyperparathyroidism, your parathyroid glands make and release too much parathyroid hormone. Your body has four parathyroid glands. They are small, pea-sized glands, located in your neck just behind your.
Patient information leaflet
Schrillkopf-Syndrom
Schrillkopf-Syndrom ist a chromosome problem caused by a missing piece of chromosome 5. The syndrome is called cri du chat (French for cry of the cat) because affected babies often have a high-pitched cry. Not all babies with the missing piece of chromosome 5 will develop cri du chat syndrome. What is cri du chat syndrome. Cri-du-chat is a rare.
Patient information leaflet
Sjögren-Syndrom
Sjögren's syndrome is an autoimmune disease that causes the glands that produce tears and saliva to stop working. It is a life-long condition but treatments can help control symptoms such as dry eyes and dry mouth. What is Sjögren's syndrome. Sjögren's syndrome is a condition that causes the tear and saliva glands to stop working. It causes dry.
Patient information leaflet
Marfan-Syndrom
Marfan-Syndrom (named after Dr Antoine Marfan, the French doctor who first described it in 1896) is a genetic disorder which people are born with and which lasts lifelong. Marfan syndrome can affect different people in different ways. Some people have mild symptoms; other people have more severe symptoms. You may have a history of Marfan syndrome.
Patient information leaflet
Hand-Arm-Vibrationssyndrom
Hand-Arm-Vibrationssyndrom (sometimes abbreviated to HAVS) causes changes in the sensation of the fingers which can lead to permanent numbness of fingers, muscle weakness and, in some cases, bouts of white finger. It is caused by working with vibrating tools. It would be unusual to develop hand-arm vibration syndrome without using vibrating tools.
Patient information leaflet
Wilms-Tumor
A Wilms' tumour ist a type of kidney cancer that usually affects young children. Wilms' tumours can appear in older children and adults but this is very rare. A Wilms' tumour is also known as a nephroblastoma Wilm's tumour is the most common type of kidney cancer in children but is very rare. What is a Wilms' tumour. A Wilms' tumour is a type of.
Weiterführende Lektüre und Referenzen
- Hyperparathyroidism-jaw tumour syndrome; MedlinePlus, National Library of Medicine.
- Bradley KJ, Cavaco BM, Bowl MR, Harding B, Cranston T, Fratter C, Besser GM, Conceicao Pereira M, Davie MW, Dudley N, Leite V, Sadler GP, Seller A, Thakker RV. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf). 2006 Mar;64(3):299-306. doi: 10.1111/j.1365-2265.2006.02460.x.
- Figueiredo AA, Saramago A, Cavaco BM, Simoes-Pereira J, Leite V. Familial parathyroid tumours-comparison of clinical profiles between syndromes. J Endocrinol Invest. 2023 Sep;46(9):1799-1806. doi: 10.1007/s40618-023-02032-4. Epub 2023 Feb 13.
- Iacobone M, Masi G, Barzon L, Porzionato A, Macchi V, Ciarleglio FA, Palu G, De Caro R, Viel G, Favia G. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg. 2009 Sep;394(5):817-25. doi: 10.1007/s00423-009-0511-y. Epub 2009 Jun 16.
- Masi G, Barzon L, Iacobone M, Viel G, Porzionato A, Macchi V, De Caro R, Favia G, Palu G. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer. 2008 Dec;15(4):1115-26. doi: 10.1677/ERC-08-0066. Epub 2008 Aug 28.
- Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat. 2010 Mar;31(3):295-307. doi: 10.1002/humu.21188.
- Tora R, Welch J, Sun J, Agarwal SK, Bell DA, Merino M, Weinstein LS, Simonds WF, Jha S. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome. J Clin Endocrinol Metab. 2023 Nov 17;108(12):3165-3177. doi: 10.1210/clinem/dgad368.
- Torresan F, Iacobone M. Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature. Int J Endocrinol. 2019 Dec 18;2019:1761030. doi: 10.1155/2019/1761030. eCollection 2019.
- van der Tuin K, Tops CMJ, Adank MA, Cobben JM, Hamdy NAT, Jongmans MC, Menko FH, van Nesselrooij BPM, Netea-Maier RT, Oosterwijk JC, Valk GD, Wolffenbuttel BHR, Hes FJ, Morreau H. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4534-4540. doi: 10.1210/jc.2017-01249.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
3. Okt 2024 | Neueste Version
1. Okt 2024 | Ursprünglich veröffentlicht
Nehmen Sie an der Diskussion teil
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Fragen, teilen, verbinden.
Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.